Cervical Cancer Prevention

Translate to Spanish or other 102 languages!

In Texas, Hispanic women have a higher incidence (15.1 per 100,000 women, compared to 8.1 per 100,000 among white women) and are 1.9 times more likely to die from the disease. Courtesy Image
In Texas, Hispanic women have a higher incidence (15.1 per 100,000 women, compared to 8.1 per 100,000 among white women) and are 1.9 times more likely to die from the disease. Courtesy Image

Mega Doctor News

- Advertisement -

Regular pap tests and HPV testing can prevent and often catch cases of cervical cancer.

Each year, approximately 13,000 women are diagnosed with cervical cancer and about 4,000 women die from cervical cancer in the US. Sixty percent of cervical cancers occur in resource- poor communities.

In Texas, Hispanic women have a higher incidence (15.1 per 100,000 women, compared to 8.1 per 100,000 among white women) and are 1.9 times more likely to die from the disease.

- Advertisement -

Hispanic women residing on the US-Mexico border have even higher cervical cancer incidence rates, a high late-diagnosis rate, and one of the highest mortality rates in the US.

Screening rates among Hispanic women along the border are suboptimal.

Courtesy Image

At Texas Tech University Health Sciences Center El Paso, the De Casa en Casa program is reducing the burden of cervical cancer by facilitating early diagnosis and access to treatment. The program offers educational sessions, no-cost cancer screenings, and diagnostic testing. The program covers 105 West Texas counties, including El Paso and Hudspeth counties.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.
- Advertisement -